Market Cap
$32.4B
ALC
ALCON INC
$63.72 ▼ -0.35%
Prev close $63.94Market cap$32.4B
ConsensusBuy
12-mo target$84.45 (+32.5%)
▲ Bullish
Analyst conviction 7/10
Congressional Activity (1) Healthcare & Medical Devices
Snapshot
The big-picture read on ALC right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (73%)
Social Sentiment
40° Cool
SEC Reports
3
Congressional
2 trades
Price chart 30d -11.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 18, 2026 short_volume
Aug 11, 2026 SEC Short Volume: ALC — 78.9% short (0.9M / 1.2M)
Short: 939,154 | Exempt: 19,115 | TRF Vol: 1,190,167 | Short Ratio: 78.9% | Off-exchange volume (dar
Alcon reported Q2 2026 net sales of $2.8 billion, up 8% YoY (7% constant currency), driven by strong performance across
6-K — Impact 6/10
Aug 5, 2026 Congress
Jul 6, 2026 SEC Kevin Hern sell
$1,001 - $15,000 — House
The Delaware Court of Chancery granted Alcon's motion to dismiss all six counts of a stockholder derivative lawsuit chal
COURT-RULING — Impact 5/10
The Delaware Chancery Court granted Alcon's motion to dismiss all six counts in a derivative lawsuit challenging conduct
COURT-RULING — Impact 5/10
Jun 26, 2026 Event
David Rostov v. Alcon Research, LLc, et al.
Court ruling (delch) — Docket: C.A. No. 2025-0648-KSJM
May 6, 2026 Event
GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alcon Laboratories, Inc., Fort Worth, Texas 76134, USA, NDC: 0065-8064-01.
Class II: Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may im
Mar 12, 2026 Congress
Josh Gottheimer sell
$1,001 - $15,000 — House
Analyst ratings buy % +7.4%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
73% rate it Buy or better · 22 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 22, 2026 | Jefferies | MAINTAIN | Buy | 53% |
| Sep 15, 2026 | Needham | REITERATE | Buy | 50% |
| Aug 12, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Aug 12, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| Aug 11, 2026 | Needham | MAINTAIN | Buy | 50% |
| Aug 11, 2026 | BTIG | REITERATE | Buy | 53% |
| Jul 15, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| May 8, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
| May 7, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| May 7, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 12 | 4 | 2 | 0 | 73% | |
| Aug 1, 2026 | 4 | 12 | 2 | 2 | 0 | 80% | |
| Jul 1, 2026 | 4 | 11 | 2 | 2 | 0 | 79% | |
| Jun 1, 2026 | 4 | 11 | 2 | 1 | 0 | 83% | |
| May 1, 2026 | 4 | 11 | 2 | 3 | 0 | 75% | |
| Apr 1, 2026 | 4 | 11 | 2 | 3 | 0 | 75% | |
| Mar 1, 2026 | 4 | 12 | 2 | 2 | 0 | 80% | |
| Feb 1, 2026 | 3 | 12 | 3 | 2 | 0 | 75% |
Price targets
Where 15 covering analysts think ALC trades over the next 12 months.
$84.45 +32.5% upside Strong Buy
Current$63.72 Low$62.00 Median$85.00 High$103.00 15 analysts
$62.00$103.00
Analyst rating Buy· 1.6/5 as of Oct 2, 2026
Social media sentiment mood +17.5%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
40°
Cool
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 3 bullish, 0 bearish, 0 mixed, 0 neutral · avg impact 5.3/10.
BULLISH6-K6/10
Alcon reported Q2 2026 net sales of $2.8 billion, up 8% YoY (7% constant currency), driven by strong
Aug 11, 2026
BULLISHCOURT-RULING5/10
The Delaware Court of Chancery granted Alcon's motion to dismiss all six counts of a stockholder der
Jul 6, 2026
BULLISHCOURT-RULING5/10
The Delaware Chancery Court granted Alcon's motion to dismiss all six counts in a derivative lawsuit
Jun 26, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 18, 2026
short_volume
Short Volume: ALC — 78.9% short (0.9M / 1.2M)
Short: 939,154 | Exempt: 19,115 | TRF Vol: 1,190,167 | Short Ratio: 78.9% | Off-exchange volume (dark pool + OTC)
Sep 17, 2026
short_volume
Short Volume: ALC — 64.1% short (0.5M / 0.8M)
Short: 496,081 | Exempt: 865 | TRF Vol: 773,828 | Short Ratio: 64.1% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_interest_report
Short Interest: ALC up 20% to 17.5M shares
Settlement 2026-09-15 | Days to cover: 11.25 | ≈3.50% of shares outstanding (est.)
Sep 14, 2026
short_volume
Short Volume: ALC — 60.2% short (0.4M / 0.6M)
Short: 359,449 | Exempt: 1,300 | TRF Vol: 596,762 | Short Ratio: 60.2% | Off-exchange volume (dark pool + OTC)
Sep 11, 2026
short_volume
Short Volume: ALC — 69.8% short (0.4M / 0.6M)
Short: 397,135 | Exempt: 2,558 | TRF Vol: 568,811 | Short Ratio: 69.8% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.89 | $0.85–$0.92 | 12.3% | +0.5% | 3↑ 4↓ | $2.7B | 13 |
| Next Q | $0.55 | $0.11–$0.74 | 25.9% | -4.4% | 2↑ 5↓ | $2.9B | 6 |
| Current FY | $3.49 | $3.37–$3.54 | 13.8% | -0.1% | 15↑ 5↓ | $11.1B | 23 |
| Next FY | $3.97 | $3.71–$4.20 | 13.6% | -0.2% | 10↑ 9↓ | $11.8B | 25 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.887 | — |
| 7d ago | $0.883 | +0.004 |
| 30d ago | $0.883 | +0.004 |
| 60d ago | $0.888 | -0.001 |
| 90d ago | $0.888 | -0.001 |
Congressional trades
ALC trades disclosed by members of Congress, with disclosure delay.
2 members · 0 buys / 2 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Kevin Hern | R | HOUSE | SELL | $1,001 - $15,000 | Alcon Inc | Sep 2, 2026(29d) |
| Mar 12, 2026 | Josh Gottheimer | D | HOUSE | SELL | $1,001 - $15,000 | Alcon Inc | Apr 9, 2026(29d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ALC.
Shares short
17,487,148
Settlement Sep 15, 2026
Change vs prior
+20.1%
Semi-monthly cycle
Days to cover
11.3
At avg daily volume
Of shares outstanding
≈3.5%
Estimate — not % of float
All ALC filing & press-release reports (3)
- 6-K reportAug 11, 2026
- COURT-RULING reportJul 6, 2026
- COURT-RULING reportJun 26, 2026